Pancreatic adenocarcinoma (PDAC) is a devastating disease with an extremely poor life expectancy and no effective treatment. Autophagy is a process of degradation of cytoplasmic component capable of recycling cellular components or eliminate specific targets. The presence of autophagy in PDAC has been demonstrated. However, the implicated cellular pathways are not fully understood and, more importantly, the role of autophagy in PDAC is matter of intensive debate. This review summarizes recently published data in an attempt to clarify the importance of autophagy in this disease and try to reconcile apparently contradictory results
Pancreatic cancer is known to have the lowest survival outcomes among all major cancers, and unfortu...
Autophagy is an evolutionarily preserved degradation process of cytoplasmic cellular constituents an...
Pancreatic cancer is a lethal disease and notoriously difficult to treat. Only a small proportion is...
Pancreatic ductal adenocarcinoma (PDAC) is one of the few cancer types where the 5-year survival rat...
Pancreatic cancer (PC) begins within the organ of the pancreas, which produces digestive enzymes, an...
International audiencePancreatic ductal adenocarcinoma (PDAC) is characterised by early metastasis a...
International audiencePancreatic ductal adenocarcinoma (PDAC) is characterised by early metastasis a...
International audiencePancreatic ductal adenocarcinoma (PDAC) is characterised by early metastasis a...
International audiencePancreatic ductal adenocarcinoma (PDAC) is characterised by early metastasis a...
Metabolic reprogramming is a feature of cancers for which recent research has been particularly acti...
International audienceMetabolic reprogramming is a feature of cancers for which recent research has ...
International audienceMetabolic reprogramming is a feature of cancers for which recent research has ...
International audienceMetabolic reprogramming is a feature of cancers for which recent research has ...
International audienceMetabolic reprogramming is a feature of cancers for which recent research has ...
Pancreatic cancer is known to have the lowest survival outcomes among all major cancers, and unfortu...
Pancreatic cancer is known to have the lowest survival outcomes among all major cancers, and unfortu...
Autophagy is an evolutionarily preserved degradation process of cytoplasmic cellular constituents an...
Pancreatic cancer is a lethal disease and notoriously difficult to treat. Only a small proportion is...
Pancreatic ductal adenocarcinoma (PDAC) is one of the few cancer types where the 5-year survival rat...
Pancreatic cancer (PC) begins within the organ of the pancreas, which produces digestive enzymes, an...
International audiencePancreatic ductal adenocarcinoma (PDAC) is characterised by early metastasis a...
International audiencePancreatic ductal adenocarcinoma (PDAC) is characterised by early metastasis a...
International audiencePancreatic ductal adenocarcinoma (PDAC) is characterised by early metastasis a...
International audiencePancreatic ductal adenocarcinoma (PDAC) is characterised by early metastasis a...
Metabolic reprogramming is a feature of cancers for which recent research has been particularly acti...
International audienceMetabolic reprogramming is a feature of cancers for which recent research has ...
International audienceMetabolic reprogramming is a feature of cancers for which recent research has ...
International audienceMetabolic reprogramming is a feature of cancers for which recent research has ...
International audienceMetabolic reprogramming is a feature of cancers for which recent research has ...
Pancreatic cancer is known to have the lowest survival outcomes among all major cancers, and unfortu...
Pancreatic cancer is known to have the lowest survival outcomes among all major cancers, and unfortu...
Autophagy is an evolutionarily preserved degradation process of cytoplasmic cellular constituents an...
Pancreatic cancer is a lethal disease and notoriously difficult to treat. Only a small proportion is...